Glaxo Leads Pharma World League, Says DDT

16 October 1994

Depending on who is counting and how, the world's top pharmaceutical companies have changed position in the sales league table from time to time, and the new Global Market Review 1994 from Definitive Data Tactics (see also Marketletter October 10) puts Glaxo at the top, with Merck & Co second. The global sales figures quoted by DDT, covering 1989 through 1993, are at ex-factory price levels and include all sales outlets, such as pharmacies, hospitals, government agencies, drug stores and international tender business.

As can be seen from the table alongside, the US and European companies continue to dominate the scene, and only one Japanese pharmaceutical company, Takeda, has crept into the top 20 league. The next ten companies include Sankyo at 21, Eisai at 28 and Shionogi Seiyaku at 30. The next 10 include five Japanese drugmakers in the list, Daiichi Pharma, Yamanouchi, Otsuka, Fujisawa, Sumitomo and Chugai.

Over the five-year period covered by the Global Review, B-MS has dropped from number one position to three, Merck has retained the number two slot, having been number one in some of the interceding years, and Glaxo, for the second year, according to the DDT data, has assumed the premier spot in the world pharmaceutical sales table.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight